Research Article
Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment
Figure 2
The expression of CXC chemokines in OC patients (GEPIA). Box plots derived from gene expression data for GEPIA comparing the expressions of CXC chemokines in ovarian cancer and normal ovarian tissue; the p value was set at 0.05. Results show that CXCL1, CXCL8, CXCL9, CXCL11, CXCL12, CXCL16, and CXCL17 were remarkably elevated in ovarian cancer compared to those in normal tissue. indicates that the results are statistically significant.